1. Home
  2. ELTX vs FSI Comparison

ELTX vs FSI Comparison

Compare ELTX & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • FSI
  • Stock Information
  • Founded
  • ELTX 2011
  • FSI 1991
  • Country
  • ELTX United States
  • FSI Canada
  • Employees
  • ELTX N/A
  • FSI N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • FSI Recreational Games/Products/Toys
  • Sector
  • ELTX Health Care
  • FSI Consumer Discretionary
  • Exchange
  • ELTX Nasdaq
  • FSI Nasdaq
  • Market Cap
  • ELTX 121.7M
  • FSI 120.2M
  • IPO Year
  • ELTX N/A
  • FSI 1999
  • Fundamental
  • Price
  • ELTX $10.13
  • FSI $10.95
  • Analyst Decision
  • ELTX Strong Buy
  • FSI
  • Analyst Count
  • ELTX 2
  • FSI 0
  • Target Price
  • ELTX $11.00
  • FSI N/A
  • AVG Volume (30 Days)
  • ELTX 139.9K
  • FSI 107.2K
  • Earning Date
  • ELTX 11-12-2025
  • FSI 11-13-2025
  • Dividend Yield
  • ELTX N/A
  • FSI 1.03%
  • EPS Growth
  • ELTX N/A
  • FSI 5.17
  • EPS
  • ELTX N/A
  • FSI 0.23
  • Revenue
  • ELTX N/A
  • FSI $37,322,073.00
  • Revenue This Year
  • ELTX N/A
  • FSI $14.14
  • Revenue Next Year
  • ELTX N/A
  • FSI $66.41
  • P/E Ratio
  • ELTX N/A
  • FSI $42.12
  • Revenue Growth
  • ELTX N/A
  • FSI N/A
  • 52 Week Low
  • ELTX $3.91
  • FSI $3.18
  • 52 Week High
  • ELTX $12.42
  • FSI $11.48
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 44.06
  • FSI 70.24
  • Support Level
  • ELTX $10.01
  • FSI $9.19
  • Resistance Level
  • ELTX $11.89
  • FSI $9.86
  • Average True Range (ATR)
  • ELTX 0.60
  • FSI 0.83
  • MACD
  • ELTX -0.08
  • FSI -0.06
  • Stochastic Oscillator
  • ELTX 6.18
  • FSI 82.76

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: